Cardiol Therapeutics Inc. (OTCMKTS:CRTPF – Get Free Report) shares were up 2% on Wednesday . The company traded as high as $1.53 and last traded at $1.50. Approximately 776,236 shares traded hands during mid-day trading, an increase of 1,057% from the average session volume of 67,097 shares. The stock had previously closed at $1.47.
Cardiol Therapeutics Price Performance
The stock’s 50 day moving average price is $1.13 and its 200-day moving average price is $1.16.
About Cardiol Therapeutics
Cardiol Therapeutics Inc is a clinical-stage biotechnology company focused on the development of novel immuno-lipid therapies for treating heart failure and inflammation-related cardiovascular diseases. The company’s proprietary platform is built on synthetic formulations of cardiolipin, a naturally occurring mitochondrial lipid known to play a key role in cellular energy production and inflammatory regulation. By harnessing the anti-inflammatory properties of cardiolipin derivatives, Cardiol aims to address unmet needs in acute and chronic cardiovascular conditions.
Cardiol’s lead product candidate, CT-1 Microspheres, is designed for intravenous administration to hospitalized patients with acute decompensated heart failure.
See Also
- Five stocks we like better than Cardiol Therapeutics
- GE Vernova’s AI Power Boom Faces a Profit Test
- Cardinal Health Earnings: Can Perfection Get Priced In Twice?
- Nebius’ Q2 Beat Shows the AI Bottleneck Is Capacity, Not Demand
- Legacy Jet Builders Stall While Embraer Accelerates to New Highs
Receive News & Ratings for Cardiol Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardiol Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
